Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8230349 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 6 Pages |
Abstract
The A/G genotype of rs10895304 is predictive of decreased recurrence-free survival in patients with clinically localized prostate cancer. Our data suggest that for this subset of patients, prostatectomy alone may not be adequate for local control. This is a novel and relevant marker that should be evaluated for improved risk stratification of patients who may be candidates for adjuvant radiation therapy to improve local control.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jerry J. M.D., Ph.D., Misun B.S., Zachary B.S., Heidi Ph.D., Geoffrey L. M.D., Carmen M.D., Ph.D., Qiuyin M.D., Ph.D., Marcia L. M.D., Bo M.D., Ph.D.,